Histone Deacetylase 6 (HDAC6) Deacetylates Survivin for Its Nuclear Export in Breast Cancer

Methylation specifies distinct estrogen-induced binding site repertoires of CBP to chromatin

(2011) D. G. Ceschin et al.   GENES & DEVELOPMENT

Survivin Monomer Plays an Essential Role in Apoptosis Regulation

(2011) Marat S. Pavlyukov et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Histone deacetylase inhibitors: A chemical genetics approach to understanding cellular functions

(2010) Paul A. Marks   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

HDAC6 is required for invadopodia activity and invasion by breast tumor cells

(2010) Mercedes Rey et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

The clinical development of histone deacetylase inhibitors as targeted anticancer drugs

(2010) Paul A Marks   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect

(2010) Michael Dickinson et al.   INVESTIGATIONAL NEW DRUGS

Acetylation Directs Survivin Nuclear Localization to Repress STAT3 Oncogenic Activity

(2010) Haijuan Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies and Solid Tumors

(2010) Mario Federico et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

The Role of HDAC6 in Cancer

(2010) Grace I. Aldana-Masangkay et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Survivin withdrawal by nuclear export failure as a physiological switch to commit cells to apoptosis

(2010) K-S Chan et al.   Cell Death & Disease

Ligand-dependent Corepressor LCoR Is an Attenuator of Progesterone-regulated Gene Expression

(2009) Ana Palijan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions

(2009) C. Choudhary et al.   SCIENCE

HDAC family: What are the cancer relevant targets?

(2008) Olaf Witt et al.   CANCER LETTERS

New wirings in the survivin networks

(2008) D C Altieri   ONCOGENE